Pleco Therapeutics

Apeldoorn, Netherlands · Founded 2018 · Privately Held (backing)

Developer of therapies intended to treat cancer and improve the effectiveness of existing chemotherapy. Pleco Therapeutics is based in Apeldoorn, Netherlands and was founded in 2018. Its last reported valuation was $25.2 million in Sep 2022. It has raised $31.1 million.

Last reported valuation
$25.2M
Oct 2026
Priced at
—
Total raised
$31.1M
Last round
—

Who backs Pleco Therapeutics?

4 investors
InvestorType
Oost NLVenture capital
Rijksdienst voor Ondernemend NederlandOther
Brabant Startup Fund—
Hyloris Pharmaceuticals—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Pleco Therapeutics investors

4 investors are on record for Pleco Therapeutics, including Oost NL, Rijksdienst voor Ondernemend Nederland, Brabant Startup Fund and Hyloris Pharmaceuticals.

Free account
More of Pleco Therapeutics with a free account
  • ·Watch Pleco Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Pleco Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View